<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04834726</url>
  </required_header>
  <id_info>
    <org_study_id>848696</org_study_id>
    <nct_id>NCT04834726</nct_id>
  </id_info>
  <brief_title>COVID-19 Vaccine Text Outreach</brief_title>
  <official_title>Pragmatic Trial of COVID Vaccine Text Outreach Interventions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project aims to evaluate different approaches to increase COVID-19 vaccine uptake among&#xD;
      at-risk patients at Penn Medicine in an equitable and systematic manner through a centralized&#xD;
      outreach program. The investigators will evaluate different text-based scheduling and&#xD;
      messaging approaches informed by behavioral science to increase uptake among eligible&#xD;
      patients, including the use of clinician endorsement, opt-out framing, and scarcity.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This project will evaluate a centralized approach to increasing COVID through direct outreach&#xD;
      to eligible patients via text messaging. This pragmatic randomized controlled trial has the&#xD;
      following aims:&#xD;
&#xD;
      Aim 1: To conduct systematic large scale text message outreach for vaccine delivery among a&#xD;
      defined group of Penn Medicine in a way that advances equity.&#xD;
&#xD;
      Aim 2: To offer different scheduling workflows through text messaging that might increase&#xD;
      uptake and reduce disparities.&#xD;
&#xD;
      Aim 3: To compare the equity and efficiency of different messages informed by behavioral&#xD;
      science, including PCP endorsement, opt-out framing, and scarcity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 29, 2021</start_date>
  <completion_date type="Actual">July 6, 2021</completion_date>
  <primary_completion_date type="Actual">June 4, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dose 1 Completion</measure>
    <time_frame>1 month</time_frame>
    <description>Percentage of patients who complete the first dose of the COVID vaccine within 1 month of initial outreach</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dose 1 Completion</measure>
    <time_frame>2 months</time_frame>
    <description>Percentage of patients who complete the first dose of the COVID vaccine within 2 months of initial outreach</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vaccine Completion</measure>
    <time_frame>2 months</time_frame>
    <description>Percentage of patients who complete the vaccination process within 2 months of initial outreach</description>
  </secondary_outcome>
  <number_of_arms>9</number_of_arms>
  <enrollment type="Actual">19554</enrollment>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>1: Usual Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive a phone call to schedule their appointment from an Access Center representative. Access Center representatives will make up to 3 attempts to schedule an appointment with the patient. Patients randomized to this arm will not receive any text messaging.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2A: Call Back + Standard Msg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The message describes that the patient is eligible for the COVID vaccine. Will include a prompt to agree to scheduling. The access center will call these patients back to schedule, calling up to 3 times.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2B: Call Back + Clinician Endorsement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The message will describe an endorsement from the provider to get the vaccination. Will include a prompt to agree to scheduling. The access center will call these patients back to schedule, calling up to 3 times.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2C: Call Back + Scarcity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The message will highlight the limited availability and the elevated priority for the patient to receive the vaccine at Penn Medicine. Will include a prompt to agree to scheduling. The access center will call these patients back to schedule, calling up to 3 times.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2D: Call Back + Opt-Out Framing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The message will highlight that a vaccine is reserved for the patient, implying that they need to opt-outWill include a prompt to agree to scheduling. The access center will call these patients back to schedule, calling up to 3 times.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3A: In-Bound Call + Standard Msg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The message describes that the patient is eligible for the COVID vaccine. Will include a prompt to agree to scheduling, which will be followed by a prompt to call the Penn Medicine Vaccine Scheduling Hotline to schedule their vaccine appointment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3B: In-Bound Call + Clinician Endorsement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The message will describe an endorsement from the provider to get the vaccination. Will include a prompt to agree to scheduling, which will be followed by a prompt to call the Penn Medicine Vaccine Scheduling Hotline to schedule their vaccine appointment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3C: In-Bound Call + Scarcity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The message will highlight the limited availability and the elevated priority for the patient to receive the vaccine at Penn Medicine. Will include a prompt to agree to scheduling, which will be followed by a prompt to call the Penn Medicine Vaccine Scheduling Hotline to schedule their vaccine appointment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3D: In-Bound Call + Opt-Out Framing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The message will highlight that a vaccine is reserved for the patient, implying that they need to opt-out. Will include a prompt to agree to scheduling, which will be followed by a prompt to call the Penn Medicine Vaccine Scheduling Hotline to schedule their vaccine appointment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Opt-In (Call-Back)</intervention_name>
    <description>Messaging will include a prompt to agree to scheduling. If patient agrees, the access center will call these patients back to schedule, calling up to 3 times.</description>
    <arm_group_label>2A: Call Back + Standard Msg</arm_group_label>
    <arm_group_label>2B: Call Back + Clinician Endorsement</arm_group_label>
    <arm_group_label>2C: Call Back + Scarcity</arm_group_label>
    <arm_group_label>2D: Call Back + Opt-Out Framing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Opt-in (In-Bound)</intervention_name>
    <description>Messaging will include a prompt to agree to scheduling followed by a prompt to call the Penn Medicine Vaccine Scheduling Hotline to schedule their vaccine appointment.</description>
    <arm_group_label>3A: In-Bound Call + Standard Msg</arm_group_label>
    <arm_group_label>3B: In-Bound Call + Clinician Endorsement</arm_group_label>
    <arm_group_label>3C: In-Bound Call + Scarcity</arm_group_label>
    <arm_group_label>3D: In-Bound Call + Opt-Out Framing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard Message</intervention_name>
    <description>The message describes that the patient is eligible for the COVID vaccine.</description>
    <arm_group_label>2A: Call Back + Standard Msg</arm_group_label>
    <arm_group_label>3A: In-Bound Call + Standard Msg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Clinician Endorsement</intervention_name>
    <description>The message will describe an endorsement from the provider to get the vaccination.</description>
    <arm_group_label>2B: Call Back + Clinician Endorsement</arm_group_label>
    <arm_group_label>3B: In-Bound Call + Clinician Endorsement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Scarcity</intervention_name>
    <description>The message will highlight the limited availability and the elevated priority for the patient to receive the vaccine at Penn Medicine.</description>
    <arm_group_label>2C: Call Back + Scarcity</arm_group_label>
    <arm_group_label>3C: In-Bound Call + Scarcity</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Opt-Out Framing</intervention_name>
    <description>This will highlight that a vaccine is reserved for the patient, implying that they need to opt-out.</description>
    <arm_group_label>2D: Call Back + Opt-Out Framing</arm_group_label>
    <arm_group_label>3D: In-Bound Call + Opt-Out Framing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Phone Call</intervention_name>
    <description>The access center will call these patients to schedule their vaccine appointment. These patients will not receive text messaging.</description>
    <arm_group_label>1: Usual Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients of Penn Medicine aged 18+ who reside in Philadelphia and who have had at&#xD;
             least 1 visit in the past 5 years with a Penn Medicine primary care provider (PCP)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who have completed any dose of the vaccine at Penn Medicine, are currently&#xD;
             scheduled to receive the vaccine, have externally documented vaccination records, or&#xD;
             have previously received text-message based vaccine outreach.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shivan Mehta, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 6, 2021</study_first_submitted>
  <study_first_submitted_qc>April 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2021</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pennsylvania</investigator_affiliation>
    <investigator_full_name>Shivan J Mehta</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Vaccination Uptake</keyword>
  <keyword>Text Messaging</keyword>
  <keyword>Outreach</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

